Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
AIDS Patient Care STDS. 2013 Feb;27(2):96-102. doi: 10.1089/apc.2012.0348.
This study aimed to characterize the experience of having a treatment supporter among HIV-infected South African patients enrolled in a randomized controlled trial that compared the efficacy of patient-nominated treatment supporters administering partial directly observed antiretroviral therapy (DOT-ART) versus self-administered ART (Self-ART). Results of the parent study showed no virologic or sustained immunologic differences between groups, but revealed a significant survival benefit among the DOT-ART group. One hypothesis is that this survival benefit may be explained by differences in the training and involvement of the treatment supporters between groups. In the current study, results from a semi-structured exit interview of 172 participants indicate that most participants in both arms maintained a positive, satisfying relationship with a single supporter, typically family member or friend. Most patients (82.6%) perceived supporters as helpful with medication adherence, with no significant difference between groups (p=0.752). Additionally, supporters provided emotional, instrumental, and material support. DOT-ART patients were more likely than Self-ART patients to report that their supporter helped to decrease drug or alcohol use (p=0.03). Patients identified supporter trustworthiness, availability, good communication and reciprocity of support as factors beneficial to a successful relationship. These results suggest: (1) Patient-nominated peers are feasible candidates for ART supporters in this resource-constrained setting; (2) In addition to assistance with medications, treatment supporters have the capacity to promote healthy behaviors and provide other types of support, which may contribute to improved outcomes, particularly with enhanced training; (3) Trustworthiness, availability, good communication, and reciprocity are key factors in a successful patient-supporter relationship.
本研究旨在描述感染艾滋病毒的南非患者在一项随机对照试验中的治疗支持体验,该试验比较了患者提名的治疗支持者实施部分直接观察抗逆转录病毒治疗(DOT-ART)与自我管理抗逆转录病毒治疗(Self-ART)的疗效。该研究的主要结果显示,两组在病毒学或持续免疫方面没有差异,但 DOT-ART 组的生存获益显著。一种假设是,这种生存获益可能与两组之间治疗支持者的培训和参与存在差异有关。在目前的研究中,对 172 名参与者进行的半结构化退出访谈结果表明,两组参与者中大多数都与一名支持者(通常是家庭成员或朋友)保持着积极、满意的关系。大多数患者(82.6%)认为支持者在药物依从性方面有所帮助,两组之间没有显著差异(p=0.752)。此外,支持者提供了情感、工具和物质支持。DOT-ART 患者比 Self-ART 患者更有可能报告其支持者帮助减少药物或酒精使用(p=0.03)。患者认为支持者的可信赖性、可用性、良好的沟通和相互支持是成功关系的有益因素。这些结果表明:(1)在资源有限的情况下,患者提名的同龄人是 ART 支持者的可行人选;(2)除了协助用药外,治疗支持者还有能力促进健康行为并提供其他类型的支持,这可能有助于改善结果,尤其是通过加强培训;(3)可信赖性、可用性、良好的沟通和相互支持是成功的患者-支持者关系的关键因素。